The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.

Dr. Ulrich Betz, Vice President Innovation; Department Head Future Insight, Merck KGaA; Department Head Innovation & Entrepreneurship Incubator, Merck Healthcare KGaA

Dr. Siegfried Bialojan, Executive Director, Head Life Science Center, Ernst & Young GmbH, Mannheim

Dr. Elmar Bourdon, Manager of Medical Technology Cluster, City of Mannheim

Prof. Dr. Bernd Bukau, Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)

Dr. Jürgen Gamer, VP Business Development Apogenix AG, Heidelberg

Dr. Jan Gradel, Director Business Development Sino German Hi Tech Park Holding GmbH, Heidelberg

Martin Haag, Site Manager, Roche Diagnostics GmbH, Mannheim

Thomas Hegendoerfer, New Ventures Lead in Germany for Johnson & Johnson Innovation, Neuss

Dr. Andreas Kempff, Managing Director, Department of Industry, Innovation and Enterprise Promotion, Chamber of Industry and Commerce (IHK) Rhine-Neckar, Heidelberg

Dr. Martin Raditsch, CEO INNOVECTIS GmbH, Frankfurt am Main

Dr. Chistian Tidona (Chair), Managing Director BioMed X GmbH, Heidelberg

Dr. Joachim Vogt, Director Search & Evaluation Western Europe at AbbVie

Dr. Alexander Wartini, CEO, ScienceValue Heidelberg GmbH Technology Transfer for the Ruprecht-Karls

University, Heidelberg

Dr. Rainer Wessel, Director Innovation Management, German Cancer Research Center (DKFZ), Heidelberg

Prof. Dr. Heike Andrea Wieland, Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main

The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects

Dr. Christoph Antz, CEO, Velabs Therapeutics GmbH, Heidelberg

Dr. Juergen Bauer, Deputy Managing Director, EMBLEM Technology Transfer GmbH, Heidelberg

Prof. Dr. Adelheid Cerwenka, Professor of Immunobiochemistry Heidelberg University, Medical Faculty Mannheim

PD Dr. Gerard Drewes, Head of Science, Cellzome GmbH – a GSK company, Heidelberg

Prof. Dr. Mathias Hafner (Chair), Vice President for Research and Technology Transfer at Mannheim University of Applied Sciences

Dr. Lena Krzyzak, Principal in Life Science Team, High-Tech Gründerfonds

Dr. Holger Hess-Stumpp, Strategic Alliance Manager Oncology, Bayer AG, Berlin

Dr. Thomas Höger, CEO and co-founder, Apogenix GmbH, Heidelberg

Prof. Dr. Carsten Hopf, Head of Institute for Instrumental Analytics and Bioanalytics Mannheim University of Applied Sciences

Dr. Friedrich Rippmann, Director, Computational Chemistry & Biology Global R&D, Discovery Technologies Merck KGaA, Darmstadt

Prof. Dr. Andreas Trumpp, Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg

​

Dr. Magnus Walter, Senior Director Drug Discovery, Medicinal Chemistry and Screening Biology, AbbVie Germany